Key facts
- This page summarizes David Patience's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Apr 2025, 18:12.
David Patience - 01 Apr 2025 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- AXDX
- Reported as of
- 01 Apr 2025
- Net transaction value
- -$4,839
- SEC form
- 4
- Accepted by SEC
- 02 Apr 2025, 18:12:07 UTC
- Prior SEC filing
- 27 Feb 2025
- Next SEC filing
- 10 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Patience
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Patience filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 02 Apr 2025.
Change
- Previous filing in this sequence was filed on 27 Feb 2025.
- Current net transaction value: -$4,839.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXDX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +20,000
- Change %
- +39%
- Price
- $0.000000
- Shares after
- 71,384
- Date
- 01 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
AXDX
transaction
Common Stock
Sale
- Transaction value
- $4,839
- Shares
- -6,816
- Change %
- -9.5%
- Price
- $0.7100
- Shares after
- 64,568
- Date
- 01 Apr 2025
- Ownership
- Direct
- Footnotes
- F2
AXDX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 760
- Date
- 01 Apr 2025
- Ownership
- By Spouse IRA
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXDX
transaction
Derivative
Employee Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -40%
- Price
- $0.000000
- Shares after
- 30,000
- Date
- 01 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
Footnote F2
The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
Footnote F3
On April 1, 2023, the reporting person was granted a total of 50,000 RSUs, of which 40% vest on April 1, 2025 and the remaining 60% vest on April 1, 2026.